Serial Measurement of Serum Antimullerian Hormone in Women Undergoing Laparoscopic Cystectomy of Endometrioma
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Mahidol University.
Recruitment status was Active, not recruiting
Information provided by:
First received: February 6, 2010
Last updated: February 16, 2010
Last verified: January 2009
The purpose of this trial is to study ovarian reserve after laparoscopic endometrioma cystectomy by measuring antimullerian hormone. The measurements were measured before the surgery and one week and three months after the surgery.
||Observational Model: Case-Only
Time Perspective: Prospective
||Serial Measurement of Serum Antimullerian Hormone in Women Undergoing Laparoscopic Cystectomy of Endometrioma
Primary Outcome Measures:
- Ovarian reserve before and after ovarian endometrioma cystectomy. [ Time Frame: one week and three months ] [ Designated as safety issue: Yes ]
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||January 2010 (Final data collection date for primary outcome measure)
ovarian endometrioma undergoing cystectomy
Antimullerian hormone will be obtained in patients with ovarian endometrioma before laparoscopic cystectomy is done. The measurements were compared with antimullerian hormone after one week and three months after the surgery. Forty three patients will be included in this study.
|Ages Eligible for Study:
||20 Years to 40 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
ovarian endometrioma performed laparoscopic cystectomy
- 20-40 years
- ovarian endometrioma > or = 3 cms
- laparoscopic cystectomy treatment
- previous ovarian surgery
- other ovarian pathology
- previous drugs or hormonal treatment for endometrioma
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01065168
||Singpetch Suksompong, Doctor
No publications provided
||Singpetch Suksompong, Mahidol University
History of Changes
|Other Study ID Numbers:
|Study First Received:
||February 6, 2010
||February 16, 2010
||Thailand: Ethical Committee
Keywords provided by Mahidol University:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on November 19, 2014
Genital Diseases, Female
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs